Patents Assigned to The CONRAD Program of the Eastern Virginia Medical School (“CONRAD”)
  • Topical antiviral formulations
    Patent number: 9283182
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: March 15, 2016
    Assignees: The CONRAD Program of the Eastern Virginia Medical School (“CONRAD”), International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl
  • Topical antiviral formulations
    Patent number: 9060933
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: June 23, 2015
    Assignees: The CONRAD Program of the Eastern Virginia Medical School (“CONRAD”), International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl